Journal article
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
- Abstract:
-
Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis virus and treated with the HIV-1 protease inhibitor ritonavir a marked inhibition of antiviral cytotoxic T lymphocyte (CTL) activity and impaired major histocompatibility complex class I-restricted ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Proceedings of the National Academy of Sciences of the United States of America
- Volume:
- 95
- Issue:
- 22
- Pages:
- 13120-13124
- Publication date:
- 1998-10-01
- DOI:
- EISSN:
-
1091-6490
- ISSN:
-
0027-8424
- Source identifiers:
-
29858
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:29858
- UUID:
-
uuid:7b706837-c6a8-4dd9-9ad6-8e712a62d7b2
- Local pid:
- pubs:29858
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 1998
If you are the owner of this record, you can report an update to it here: Report update to this record